Boston Scientific Corporation’s BSX successful result from its WHISPER randomized controlled trial (RCT) further boosts its neuromodulation business. This announcement follows the recent FDA approval ...
Medical Device Network on MSN
NHS Trust completes UK’s first SCS implant in adolescent patient
Upon completion of the SCS neuromodulation implant procedure, the chronic pain 18-year-old Ralph Seed had experienced for the ...
DUBLIN--(BUSINESS WIRE)--The "Neuromodulation Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. Neuromodulation is an intracranial, ...
Medical Device Network on MSN
BIOTRONIK Neuro acquires Soin Neuroscience’s SCS IP portfolio
The acquisition follows a previous research collaboration between Soin Neuroscience and BIOTRONIK Neuro in December 2025.
Abbott ABT recently announced the first usage of its Eterna spinal cord stimulator (SCS) system in Canada. This marks a significant milestone in the company’s approach to chronic pain management. The ...
Abbott announced new five-year data demonstrating that its neuromodulation therapies, including its proprietary BurstDR spinal cord stimulation (SCS) waveform and dorsal root ganglion stimulation ...
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Stimwave Technologies, a leading innovator in wireless medical device technology, a manufacturer and an independent research institute headquartered in Fort ...
Prominent players in the neuromodulation market include Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), LivaNova PLC (UK), Nevro Corp (US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results